R A Larson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R A Larson

Showing results (161-170 of 208) with videos related to

Pageof 21

Sort By:

Leukemia|November 10, 2012

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemiaO G Ottmann, R A Larson, H M Kantarjian, et al.

Blood|December 15, 1992

Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762)C A Westbrook, A L Hooberman, C Spino, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987

Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disordersM J Pettenati, M M Le Beau, R S Lemons, et al.

Blood|March 15, 1992

Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disordersW L Neuman, C M Rubin, R B Rios, et al.

Leukemia & Lymphoma|July 1, 1994

Phase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignanciesL C Platanias, M J Ratain, S O'Brien, et al.

Leukemia|February 1, 1988

Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivoB L Samuels, R A Larson, M M Le Beau, et al.

Leukemia|March 20, 2015

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcomaZ Li, F Stölzel, K Onel, et al.

Leukemia|December 1, 1989

The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphomaM M Le Beau, M A Bitter, R A Larson, et al.

Blood|November 1, 1987

Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lungM J Ratain, L S Kaminer, J D Bitran, et al.

Blood|April 15, 1995

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811R A Larson, R K Dodge, C P Burns, et al.

Pageof 21

Search research articles

Showing results (161-170 of 208) with videos related to

Sort By:

Pageof 21

Leukemia|November 10, 2012

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemiaO G Ottmann, R A Larson, H M Kantarjian, et al.

Blood|December 15, 1992

Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762)C A Westbrook, A L Hooberman, C Spino, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987

Blood|March 15, 1992

Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disordersW L Neuman, C M Rubin, R B Rios, et al.

Leukemia & Lymphoma|July 1, 1994

Leukemia|February 1, 1988

Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivoB L Samuels, R A Larson, M M Le Beau, et al.

Leukemia|March 20, 2015

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcomaZ Li, F Stölzel, K Onel, et al.

Leukemia|December 1, 1989

The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphomaM M Le Beau, M A Bitter, R A Larson, et al.

Blood|November 1, 1987

Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lungM J Ratain, L S Kaminer, J D Bitran, et al.

Blood|April 15, 1995

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811R A Larson, R K Dodge, C P Burns, et al.

Pageof 21